ChemoCentryx, Inc.·4

May 12, 7:46 PM ET

ChemoCentryx, Inc. 4

4 · ChemoCentryx, Inc. · Filed May 12, 2016

Insider Transaction Report

Form 4
Period: 2016-05-09
SINGH RAJINDER
SVP, Research
Transactions
  • Award

    Stock Option (right to buy)

    2016-05-09+180,000180,000 total
    Exercise: $2.10Exp: 2026-05-09Common Stock (180,000 underlying)
Footnotes (2)
  • [F1]The option was granted on May 9, 2016. 25% of the total number of shares of common stock subject to the option will vest on May 2, 2017, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
  • [F2]Not applicable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION